Auvi-Q tv commercials
TV spots
TV commercials Auvi-Q
The Auvi-Q TV Spot is a commercial that highlights the features and benefits of the Auvi-Q device, an epinephrine auto-injector used to treat severe allergic reactions, including anaphylaxis. The commercial opens with a woman sitting on a couch looking at a picture of her daughter when she was much...
Agenices
Agencies worked with Auvi-Q
Havas Media
Havas Media is a global advertising and communications company that was founded in 1835 by Charles-Louis Havas. The company has a presence in over 100 countries worldwide and is a part of the larger Havas Group. Havas Media specializes in media planning and buying, data and insights, and content creation and distribution. The company works with a wide range of clients including global brands, small businesses, and local organizations across a var...
Actors
Actors who starred in Auvi-Q commercials
What kind of company is Auvi-Q?
IntroductionAuvi-Q is an epinephrine auto-injector device used for emergency treatment of severe allergic reactions, also known as anaphylaxis. The device was developed by the healthcare company, kaleo, and it was approved by the United States Food and Drug Administration (FDA) in 2012. In this response, I will provide a brief background of the company and then focus on Auvi-Q.
Company BackgroundKaleo was founded in 2004 with the mission of developing innovative therapies to improve patient outcomes. The company is based in Richmond, Virginia, and it is privately owned. Kaleo focuses on developing treatments for a variety of conditions, including anaphylaxis, opioid overdoses, and migraines.
About Auvi-QAuvi-Q is a unique auto-injector device because it provides voice instructions to guide users through the injection process. The device is designed to be compact, easy to carry, and user-friendly. The voice instructions are available in both English and Spanish. Auvi-Q can deliver a single dose of epinephrine and it is available in two dosages: 0.1mg and 0.15mg.
AvailabilityAuvi-Q is available in the United States through authorized distributors for schools, first responders, and daycares. Additionally, the device can be purchased through insurance, and kaleo offers a copay assistance program to help reduce the cost for eligible patients. The device currently costs $360 for a two-pack without insurance.
ConclusionAuvi-Q offers a unique approach to treating anaphylaxis with its voice-guided instructions and compact design. The device is one of several products developed by kaleo to improve patient outcomes. While the cost of Auvi-Q may be a barrier for some patients, the company provides resources to help make the device more affordable. Overall, Auvi-Q is a valuable option for patients at risk of severe allergic reactions.
